Articles From This Issue
COVER FOCUS
The Unknowns of the Outflow Pathway
By Ronald L. Fellman, MD; and Davinder S. Grover, MD, MPH
A better understanding of what governs the homeostasis of outflow is vital to understanding the early pathology of glaucoma.
COVER FOCUS
The Suprachoroidal Space: The Next Frontier
By R. Allan Sharpe, MD; and Peter T. Chang, MD
A look at emerging technologies targeting the suprachoroidal space.
CASE FILES
Glaucoma or Something Else?
By Douglas J. Rhee, MD; Thomas Patrianakos, MD; Shakeel Shareef, MD; and Arthur J. Sit, MD
Physicians explore whether another form of optic neuropathy caused this patient’s visual field loss.
Supplements and CME
Current and Future Glaucoma Management: An Update on Existing Options and the Therapeutic Pipeline
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
XEN Needling Case Examples
Sponsored by Allergan
NEWS
EyeGate Pharma Submits Investigational Device Exemption Amendment for Second Pil…
EyeGate Pharmaceuticals announced that it has submitted an amended Investigational Device Exemption …
Icon Bioscience Receives FDA Approval for Dexycu Drug Therapy for Treating Infla…
Icon Bioscience announced that the FDA has approved the company's new drug application for Dexyc…
EyeGate Announces Topline Results for Phase 2b Trial of EGP-437 in Cataract Surg…
EyeGate Pharmaceuticals announced topline results from a phase 2b study of EGP-437 combination produ…
Patients Are Going Blind Due to 6-Month Waiting Lists for Cataract Surgery
Patients face going blind while waiting for cataract surgery after new figures showed waiting times …
Featured Content
